{"id":691233,"date":"2022-10-03T09:04:50","date_gmt":"2022-10-03T13:04:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/"},"modified":"2022-10-03T09:04:50","modified_gmt":"2022-10-03T13:04:50","slug":"rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/","title":{"rendered":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdecimal { list-style-type: decimal }\n.bwlistlowalpha { list-style-type: lower-alpha }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Rubric Capital Management Increases Slate of Proposed Mereo BioPharma<\/b><b>Director Nominees to Five<\/b><\/p>\n<p class=\"bwalignc\"><b><i>Director Nominees Possess the Financial, Regulatory and Strategic Expertise to Maximize Value for All Shareholders<\/i><\/b><\/p>\n<p class=\"bwalignc\"><b><i>Details Mereo\u2019s Desperate Efforts to Thwart Requisition of General Meeting of Shareholders<\/i><\/b><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRubric Capital Management LP (\u201cRubric\u201d), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (\u201cMereo\u201d or the \u201cCompany\u201d), today issued an open letter to Mereo\u2019s shareholders. In its letter, Rubric details Mereo\u2019s entrenching tactics in a desperate attempt to once more thwart Rubric\u2019s effort to call a general meeting of shareholders.\n<\/p>\n<p>\nRubric has delivered yet another revised requisition today and is increasing the size of its slate of proposed directors to five director nominees, who it believes will provide the Board with the financial, regulatory, and strategic expertise to maximize value for all shareholders. The five highly qualified candidates for Mereo\u2019s Board are: Annalisa Jenkins, MBBS, FRCP, Daniel Shames, MD, Marc Yoskowitz, Justin Roberts, and David Rosen.\n<\/p>\n<p>\nThe full text of the letter follows:\n<\/p>\n<p>\nDear Fellow Mereo Shareholders,\n<\/p>\n<p>\nThe Mereo Board has once again rejected our request for a special meeting based on the flimsiest of pretexts. On this occasion they cite the \u201cbasic legal requirement\u201d that the requisition be delivered by a \u201cregistered shareholder\u201d. On its face, this seems like a reasonable request but for the following facts they, once again, conveniently omit:\n<\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nRubric delivered a requisition from two members. This included letters from our prime brokers, who maintain all shares within omnibus accounts, attesting to the fact that two funds managed by Rubric beneficially own Ordinary Shares in Mereo BioPharma in sufficient number to call a general meeting of shareholders\n<\/li>\n<li>\nIn rejecting those attestation letters, the Board required Rubric (and, for the record, any other shareholder who wishes in the future to exercise their rights) to do the following:<\/p>\n<ol class=\"bwlistlowalpha\">\n<li>\nConvert digital holdings of Ordinary Shares into <span class=\"bwuline\">paper shareholder certificates<\/span>, a process that was tedious, time consuming, and adds significant risk to maintaining proper custody on behalf of Rubric\u2019s managed funds\n<\/li>\n<li>\nRequest our prime brokers then to go to CREST, the electronic registry for the majority of the UK market, to have it remove the Shares from the digital records so our proof of ownership could be maintained on the <span class=\"bwuline\">physical certificates<\/span><\/li>\n<li>\nFinally, request our prime brokers to store our certificated shares in their respective <span class=\"bwuline\">vaults<\/span> for safekeeping\n<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>\nGiven the lengths this Board has gone to so far to prevent this requisition, if the vaults are the victim of a heist I think we can narrow the suspect list <i>considerably<\/i>.\n<\/p>\n<p>\nNot since CSX held its 2008 annual meeting in an \u201cinaccessible rail yard\u201d in a futile attempt to prevent TCI\/3G\u2019s proxy challenge have we seen such depths of entrenchment and wasteful use of shareholder resources. These tactics have not deterred Rubric from its efforts, and we have completed them in order to deliver yet another revised requisition today.\n<\/p>\n<p>\nRubric has attempted, throughout this process, to operate with transparency about our intentions and clearly communicate as to why we believe our course of action to be in the best interests of shareholders. Our requests have thus far been met with bad faith, in both word and deed, by the Mereo Board.\n<\/p>\n<p>\nIt is clear to Rubric (and we hope other shareholders) that the problems on the Board of Mereo run deeper than we anticipated. In light of this development and our belief that further boardroom change is required to achieve the best outcome for shareholders, we are increasing the size of our slate of proposed directors to <span class=\"bwuline\">five<\/span> in order to accommodate my nomination. My nomination will further bolster our strong slate of existing nominees and we believe will provide the Board with the financial, regulatory, and strategic expertise to maximize value for all shareholders.\n<\/p>\n<p>\nSincerely,\n<\/p>\n<p>\nDavid Rosen\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20221003005384\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20221003005384\/en\/<\/a><\/span><\/p>\n<p>\nMedia:<br \/>\n<br \/>Jonathan Gasthalter\/Sam Fisher<br \/>\n<br \/>Gasthalter &amp; Co.<br \/>\n<br \/>(212) 257-4170\n<\/p>\n<p>\nInvestors:<br \/>\n<br \/>Okapi Partners LLC<br \/>\n<br \/>Bruce Goldfarb \/ Jason Alexander<br \/>\n<br \/>(212) 297-0720<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:info@okapipartners.com\">info@okapipartners.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York North America United States Ireland United Kingdom Europe<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Professional Services Health Finance General Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221003005384\/en\/1589332\/3\/Rubric_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five Director Nominees Possess the Financial, Regulatory and Strategic Expertise to Maximize Value for All Shareholders Details Mereo\u2019s Desperate Efforts to Thwart Requisition of General Meeting of Shareholders NEW YORK&#8211;(BUSINESS WIRE)&#8211; Rubric Capital Management LP (\u201cRubric\u201d), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (\u201cMereo\u201d or the \u201cCompany\u201d), today issued an open letter to Mereo\u2019s shareholders. In its letter, Rubric details Mereo\u2019s entrenching tactics in a desperate attempt to once more thwart Rubric\u2019s effort to call a general meeting of shareholders. Rubric has delivered yet another revised requisition today and is increasing the size of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-691233","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five Director Nominees Possess the Financial, Regulatory and Strategic Expertise to Maximize Value for All Shareholders Details Mereo\u2019s Desperate Efforts to Thwart Requisition of General Meeting of Shareholders NEW YORK&#8211;(BUSINESS WIRE)&#8211; Rubric Capital Management LP (\u201cRubric\u201d), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (\u201cMereo\u201d or the \u201cCompany\u201d), today issued an open letter to Mereo\u2019s shareholders. In its letter, Rubric details Mereo\u2019s entrenching tactics in a desperate attempt to once more thwart Rubric\u2019s effort to call a general meeting of shareholders. Rubric has delivered yet another revised requisition today and is increasing the size of &hellip; Continue reading &quot;Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T13:04:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five\",\"datePublished\":\"2022-10-03T13:04:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/\"},\"wordCount\":721,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/\",\"name\":\"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2022-10-03T13:04:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/","og_locale":"en_US","og_type":"article","og_title":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk","og_description":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five Director Nominees Possess the Financial, Regulatory and Strategic Expertise to Maximize Value for All Shareholders Details Mereo\u2019s Desperate Efforts to Thwart Requisition of General Meeting of Shareholders NEW YORK&#8211;(BUSINESS WIRE)&#8211; Rubric Capital Management LP (\u201cRubric\u201d), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (\u201cMereo\u201d or the \u201cCompany\u201d), today issued an open letter to Mereo\u2019s shareholders. In its letter, Rubric details Mereo\u2019s entrenching tactics in a desperate attempt to once more thwart Rubric\u2019s effort to call a general meeting of shareholders. Rubric has delivered yet another revised requisition today and is increasing the size of &hellip; Continue reading \"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-03T13:04:50+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five","datePublished":"2022-10-03T13:04:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/"},"wordCount":721,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/","name":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2022-10-03T13:04:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221003005384r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rubric-capital-management-increases-slate-of-proposed-mereo-biopharmadirector-nominees-to-five\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/691233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=691233"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/691233\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=691233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=691233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=691233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}